These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 19579814

  • 1. Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients.
    Baczkowska T, Durlik M.
    Pol Arch Med Wewn; 2009 May; 119(5):318-25. PubMed ID: 19579814
    [Abstract] [Full Text] [Related]

  • 2. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM, Kobashigawa J, Klintmalm G.
    Clin Transplant; 2008 May; 22(1):1-15. PubMed ID: 18217899
    [Abstract] [Full Text] [Related]

  • 3. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B, Höcker B.
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [Abstract] [Full Text] [Related]

  • 4. Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments.
    Giessing M, Fuller TF, Tuellmann M, Slowinski T, Budde K, Liefeldt L.
    World J Urol; 2007 Jun; 25(3):325-32. PubMed ID: 17333201
    [Abstract] [Full Text] [Related]

  • 5. Calcineurin-inhibitor-sparing immunosuppressive protocols.
    Bestard O, Cruzado JM, Grinyó JM.
    Transplant Proc; 2005 Nov; 37(9):3729-32. PubMed ID: 16386520
    [Abstract] [Full Text] [Related]

  • 6. Calcineurin inhibitor-free protocols: risks and benefits.
    Barbari AG, Stephan AG, Masri MA.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):1-23. PubMed ID: 17237886
    [Abstract] [Full Text] [Related]

  • 7. Impact of calcineurin-inhibitor conversion to mTOR inhibitor on renal allograft function in a prednisone-free regimen.
    Chhabra D, Alvarado A, Dalal P, Leventhal J, Wang C, Sustento-Reodica N, Najafian N, Skaro A, Levitsky J, Mas V, Gallon L.
    Am J Transplant; 2013 Nov; 13(11):2902-11. PubMed ID: 24007570
    [Abstract] [Full Text] [Related]

  • 8. The safety and efficacy of early withdrawal of calcineurin inhibitors in kidney transplant recipients 6 months' posttransplant.
    Boswell A, Evans L, Rigg K, Shehata M.
    Transplant Proc; 2005 Mar; 37(2):884-5. PubMed ID: 15848564
    [Abstract] [Full Text] [Related]

  • 9. Calcineurin inhibitor-free immunosuppression in kidney transplantation.
    Guerra G, Srinivas TR, Meier-Kriesche HU.
    Transpl Int; 2007 Oct; 20(10):813-27. PubMed ID: 17645419
    [Abstract] [Full Text] [Related]

  • 10. High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study.
    Burkhalter F, Oettl T, Descoeudres B, Bachmann A, Guerke L, Mihatsch MJ, Dickenmann M, Steiger J.
    Transplant Proc; 2012 Dec; 44(10):2961-5. PubMed ID: 23195006
    [Abstract] [Full Text] [Related]

  • 11. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
    Asberg A, Midtvedt K, Line PD, Narverud J, Holdaas H, Jenssen T, Reisaeter AV, Johnsen LF, Fauchald P, Hartmann A.
    Transplantation; 2006 Jul 15; 82(1):62-8. PubMed ID: 16861943
    [Abstract] [Full Text] [Related]

  • 12. Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation.
    Vincenti F, Ramos E, Brattstrom C, Cho S, Ekberg H, Grinyo J, Johnson R, Kuypers D, Stuart F, Khanna A, Navarro M, Nashan B.
    Transplantation; 2001 May 15; 71(9):1282-7. PubMed ID: 11397963
    [Abstract] [Full Text] [Related]

  • 13. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 14. Calcineurin inhibitor sparing in renal transplantation.
    Ekberg H.
    Transplantation; 2008 Sep 27; 86(6):761-7. PubMed ID: 18813097
    [Abstract] [Full Text] [Related]

  • 15. Calcineurin inhibitor-sparing regimens based on mycophenolic acid after kidney transplantation.
    Kamar N, Del Bello A, Belliere J, Rostaing L.
    Transpl Int; 2015 Aug 27; 28(8):928-37. PubMed ID: 25557802
    [Abstract] [Full Text] [Related]

  • 16. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum.
    Tredger JM, Brown NW, Dhawan A.
    Drugs; 2008 Aug 27; 68(10):1385-414. PubMed ID: 18578558
    [Abstract] [Full Text] [Related]

  • 17. Minimizing calcineurin inhibitor drugs in renal transplantation.
    Flechner SM.
    Transplant Proc; 2003 May 27; 35(3 Suppl):118S-121S. PubMed ID: 12742481
    [Abstract] [Full Text] [Related]

  • 18. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
    Issa N, Kukla A, Ibrahim HN.
    Am J Nephrol; 2013 May 27; 37(6):602-12. PubMed ID: 23796509
    [Abstract] [Full Text] [Related]

  • 19. Early withdrawal of calcineurin inhibitor from a sirolimus-based immunosuppression stabilizes fibrosis and the transforming growth factor-β signalling pathway in kidney transplant.
    Rivelli RF, Gonçalves RT, Leite M, Santos MA, Delgado AG, Cardoso LR, Takiya CM.
    Nephrology (Carlton); 2015 Mar 27; 20(3):168-76. PubMed ID: 25404086
    [Abstract] [Full Text] [Related]

  • 20. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
    Helal I, Chan L.
    Transplant Proc; 2011 Mar 27; 43(2):472-7. PubMed ID: 21440737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.